Novel approach for characterizing ubiquitin E3 ligase function

Journal of Biomolecular Screening

Volumn 15, Issue 10, 2010, Pages 1220-1228

  Marblestone, Jeffrey G ^a   Kumar, K G Suresh ^a   Eddins, Michael J ^a   Leach, Craig A ^a   Sterner, David E ^a   Mattern, Michael R ^a   Nicholson, Benjamin ^a  

^a Progenra Inc   (United States)

Author keywords

assay; CARP2; drug discovery; high throughput screening; ubiquitylation

Indexed keywords

POLYUBIQUITIN; UBIQUITIN PROTEIN LIGASE E3;

ARTICLE; ENZYME ACTIVITY; ENZYME ASSAY; HIGH THROUGHPUT SCREENING; HUMAN; MONITORING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; UBIQUITINATION;

DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; DRUG DISCOVERY; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; LUMINESCENCE; NERVE TISSUE PROTEINS; POLYUBIQUITIN; SACCHAROMYCES CEREVISIAE PROTEINS; SMALL MOLECULE LIBRARIES; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; UBIQUITIN-ACTIVATING ENZYMES; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 78650113602     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057110380456     Document Type: Article

References (30)

1. Hershko A., Ciechanover A.: The ubiquitin system. Annu Rev Biochem 1998 ; 67: 425-479.
2. Sun L., Chen ZJ: The novel functions of ubiquitination in signaling. Curr Opin Cell Biol 2004 ; 16: 119-126.
3. Pickart CM, Fushman D.: Polyubiquitin chains: polymeric protein signals. Curr Opin Chem Biol 2004 ; 8: 610-616.
4. Ciechanover A.: The ubiquitin-proteasomal pathway: on protein death and cell life. Embo J 1998 ; 17: 7151-7160.
5. Hicke L.: Protein regulation by monoubiquitin. Nat Rev Mol Cell Biol 2001 ; 2: 195-201.
6. Welchman RL, Gordon C., Mayer RJ: Ubiquitin and ubiquitin-like proteins as multifunctional signals. Nat Rev Mol Cell Biol 2005 ; 6: 599-609.
7. Chauhan D., Singh A., Brahmandam M., Podar K., Hideshima T., Richardson P.,, et al. Combination of proteasome inhibitors bortezomib and NPI-0052 trigger in vivo synergistic cytotoxicity in multiple myeloma. Blood 2008 ; 111: 1654-1664.
8. Goldenberg SJ, Marblestone JG, Mattern MR, Nicholson B.: Strategies for the identification of ubiquitin ligase inhibitors. Biochem Soc Trans 2010 ; 38 (pt 1). 132-136.
9. Ardley HC: Ring finger ubiquitin protein ligases and their implication to the pathogenesis of human diseases. Curr Pharm Des 2009 ; 15: 3697-3715.
10. Nakayama KI, Nakayama K.: Ubiquitin ligases: cell-cycle control and cancer. Nat Rev Cancer 2006 ; 6: 369-381.
11. Ardley HC, Robinson PA: The role of ubiquitin-protein ligases in neurodegenerative disease. Neurodegener Dis 2004 ; 1: 71-87.
12. Petroski MD: The ubiquitin system, disease, and drug discovery. BMC Biochem 2008 ; 9 (suppl 1). S7.
13. Deveraux Q., Ustrell V., Pickart C., Rechsteiner M.: A 26 S protease subunit that binds ubiquitin conjugates. J Biol Chem 1994 ; 269: 7059-7061.
14. Su V., Lau AF: Ubiquitin-like and ubiquitin-associated domain proteins: significance in proteasomal degradation. Cell Mol Life Sci 2009 ; 66: 2819-2833.
15. Hurley JH, Lee S., Prag G.: Ubiquitin-binding domains. Biochem J 2006 ; 399: 361-372.
16. Schnell JD, Hicke L.: Non-traditional functions of ubiquitin and ubiquitin-binding proteins. J Biol Chem 2003 ; 278: 35857-35860. (Pubitemid 37139902)
17. Grabbe C., Dikic I.: Functional roles of ubiquitin-like domain (ULD) and ubiquitin-binding domain (UBD) containing proteins. Chem Rev 2009 ; 109: 1481-1494.
18. Raasi S., Varadan R., Fushman D., Pickart CM: Diverse polyubiquitin interaction properties of ubiquitin-associated domains. Nat Struct Mol Biol 2005 ; 12: 708-714.
19. McDonald ER III, El-Deiry WS: Suppression of caspase-8- and -10-associated RING proteins results in sensitization to death ligands and inhibition of tumor cell growth. Proc Natl Acad Sci U S A 2004 ; 101: 6170-6175.
20. Maniatis T., Fritsch EF, Sambrook J.: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1983.
21. Raasi S., Pickart CM: Rad23 ubiquitin-associated domains (UBA) inhibit 26 S proteasome-catalyzed proteolysis by sequestering lysine 48-linked polyubiquitin chains. J Biol Chem 2003 ; 278: 8951-8959.
22. Raasi S., Orlov I., Fleming KG, Pickart CM: Binding of polyubiquitin chains to ubiquitin-associated (UBA) domains of HHR23A. J Mol Biol 2004 ; 341: 1367-1379.
23. Yang W., El-Deiry WS: CARPs are E3 ligases that target apical caspases and p53. Cancer Biol Ther 2007 ; 6: 1676-1683.
24. Kim HT, Kim KP, Lledias F., Kisselev AF, Scaglione KM, Skowyra D.,, et al. Certain pairs of ubiquitin-conjugating enzymes (E2s) and ubiquitin-protein ligases (E3s) synthesize nondegradable forked ubiquitin chains containing all possible isopeptide linkages. J Biol Chem 2007 ; 282: 17375-17386.
25. Anan T., Nagata Y., Koga H., Honda Y., Yabuki N., Miyamoto C.,, et al. Human ubiquitin-protein ligase Nedd4: expression, subcellular localization and selective interaction with ubiquitin-conjugating enzymes. Genes Cells 1998 ; 3: 751-763.
26. Zhang JH, Chung TD, Oldenburg KR: A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 1999 ; 4: 67-73.
27. Davydov IV, Woods D., Safiran YJ, Oberoi P., Fearnhead HO, Fang S.,, et al. Assay for ubiquitin ligase activity: high-throughput screen for inhibitors of HDM2. J Biomol Screen 2004 ; 9: 695-703.
28. Cassaday J., Shah T., Murray J., O'Donnell GT, Kornienko O., Strulovici B.,, et al. Miniaturization and automation of an ubiquitin ligase cascade enzyme-linked immunosorbent assay in 1,536-well format. Assay Drug Dev Technol 2007 ; 5: 493-500.
29. Ferrer M., Zuck P., Kolodin G., Mao SS, Peltier RR, Bailey C.,, et al. Miniaturizable homogenous time-resolved fluorescence assay for carboxypeptidase B activity. Anal Biochem 2003 ; 317: 94-98.
30. Sasiela CA, Stewart DH, Kitagaki J., Safiran YJ, Yang Y., Weissman AM,, et al. Identification of inhibitors for MDM2 ubiquitin ligase activity from natural product extracts by a novel high-throughput electrochemiluminescent screen. J Biomol Screen 2008 ; 13: 229-237.